{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:04:29Z","timestamp":1787090669998,"version":"build-2736575974"},"reference-count":80,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Development and Industrial Pharmacy"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/03639045.2026.2628937","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T11:11:23Z","timestamp":1770549083000},"page":"649-666","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Quality by design in parenteral drug development: addressing formulation challenges and industrial insights"],"prefix":"10.1080","volume":"52","author":[{"given":"Kanika","family":"Thakur","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Shoolini University","place":["Solan, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran Deep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Chitkara University School of Pharmacy, Chitkara University","place":["Baddi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditsaah","family":"Kak","sequence":"additional","affiliation":[{"name":"Department of Applied Sciences and Biotechnology, Shoolini University","place":["Solan, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak N.","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Chandigarh Group of Colleges Jhanjeri, Mohali, Chandigarh Pharmacy College, Jhanjeri","place":["Mohali Punjab, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"3","key":"e_1_3_3_2_1","first-page":"242","article-title":"A review on","volume":"22","author":"Vamsidhar M","year":"2021","unstructured":"Vamsidhar M, Divya K, Divyasree R, et al. A review on. Parenteral Drug Delivery System. 2021;22(3):242\u2013272. www.ijppr.humanjournals.comwww.ijppr.humanjournals.com.","journal-title":"Parenteral Drug Delivery System"},{"issue":"2","key":"e_1_3_3_3_1","first-page":"325","article-title":"Parenteral dosage forms in pharmaceutical preformulation and formulation","volume":"199","author":"Broadhead J","year":"2009","unstructured":"Broadhead J, Gibson M. Parenteral dosage forms in pharmaceutical preformulation and formulation. Swarbrick James. 2009;199(2):325\u2013347.","journal-title":"Swarbrick James"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780367821678-5"},{"key":"e_1_3_3_5_1","unstructured":"Overcoming Excipient Risks and Challenges for Parenteral Formulations. Available from: https:\/\/www.sigmaaldrich.com\/IN\/en\/technical-documents\/technical-article\/pharmaceutical-and-biopharmaceutical-manufacturing\/classical-pharma-manufacturing\/excipients-parenteral-formulations."},{"key":"e_1_3_3_6_1","first-page":"2","article-title":"Quality by design (QbD): a new concept for development of quality pharmaceuticals","volume":"4","author":"Patil AS","year":"2013","unstructured":"Patil AS, Pethe AM. Quality by design (QbD): a new concept for development of quality pharmaceuticals. Int J Pharm Qual Assuran. 2013;4:2. www.ijpqa.com.","journal-title":"Int J Pharm Qual Assuran"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9598-3"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.124163"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-99-8034-5_14"},{"key":"e_1_3_3_10_1","volume-title":"Juran on quality by design: the new steps for planning quality into goods and services","author":"Juran JM.","year":"1992","unstructured":"Juran JM. Juran on quality by design: the new steps for planning quality into goods and services. The Free Press, A division of Simon and Schuster Inc. 1230 Avenue of the Americas; 1992."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.33320\/maced.pharm.bull.2011.57.010"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-020-00254-9"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/605427"},{"key":"e_1_3_3_14_1","unstructured":"Balasaheb Jadhav J NN Chaudhari RA. Quality by design (QBD). Approach used in development of pharmaceuticals; 2014. Available from: www.ijpab.com."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9566-x"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.03.052"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.52711\/2231-5713.2024.00008"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.24843\/JPSA.2024.v06.i02.p02"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01079-w"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121700"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030287"},{"key":"e_1_3_3_22_1","unstructured":"Jain S John S. Quality by design (QBD): a comprehensive understanding of implementation and challenges in pharmaceuticals development; 2014. Available from: https:\/\/www.researchgate.net\/publication\/280019162."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68215"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130640"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1515\/pthp-2019-0020"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-14968-4_3"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1109\/IUCC-CIT-DSCI-SmartCNS55181.2021.00028"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-5-120"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.37521\/ejpps.24302"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5713.2019.00045.X"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-815799-2.00003-4"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2017.1291672"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.01.006"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106275"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01758-9"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.07.004"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-014-0274-9"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105629"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111940"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2018.1508220"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4PM00201F"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/02678292.2020.1836276"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-021-09541-w"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118717"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/applnano6010004"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.5155\/eurjchem.8.4.430-433.1667"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060919"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.30574\/gscbps.2024.26.1.0019"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2016.01.003"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2023.12.008"},{"issue":"2","key":"e_1_3_3_51_1","first-page":"20","article-title":"Quality by design (QbD): a complete review","volume":"17","author":"Nadpara NP","year":"2012","unstructured":"Nadpara NP, Thumar RV, Kalola VN, et al. Quality by design (QbD): a complete review. Int J Pharm Sci Rev Res. 2012;17(2):20\u201328.","journal-title":"Int J Pharm Sci Rev Res"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17050623"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.4155\/pbp.14.24"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.028"},{"key":"e_1_3_3_55_1","volume-title":"Development and manufacture of drug substances (chemical entities and biotechnological\/biological entities)","author":"ICH Q11","year":"2012","unstructured":"ICH Q11. Development and manufacture of drug substances (chemical entities and biotechnological\/biological entities). Amsterdam, The Netherlands: ICH; 2012."},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102752"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.25258\/ijpqa.15.3.93"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2019.12.007"},{"key":"e_1_3_3_59_1","unstructured":"Januvia INN-Sitagliptin. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/januvia-epar-product-information_en.pdf."},{"key":"e_1_3_3_60_1","unstructured":"Eziokwu NV. Quality by design (Qbd): manufacturing and product quality of generics drugs perspective; 2013. Available from: www.JGTPS.com."},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.79"},{"issue":"6","key":"e_1_3_3_62_1","first-page":"527","article-title":"Application of quality by design (QbD) principles to extractables\/leachables assessment. establishing a design space for terminally sterilized aqueous drug products stored in a plastic packaging system","volume":"64","author":"Jenke D.","year":"2010","unstructured":"Jenke D. Application of quality by design (QbD) principles to extractables\/leachables assessment. establishing a design space for terminally sterilized aqueous drug products stored in a plastic packaging system. PDA J Pharm Sci Technol. 2010;64(6):527\u2013535.","journal-title":"PDA J Pharm Sci Technol"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/chrsci\/49.6.439"},{"key":"e_1_3_3_64_1","unstructured":"Serra M. Continuous quality is essential in parenteral manufacturing. Grifols; 2018. Available from: https:\/\/www.pharmasalmanac.com\/articles\/continuous-quality-is-essential-in-parenteral-manufacturing."},{"issue":"12","key":"e_1_3_3_65_1","first-page":"1","article-title":"Implementing QbD in sterile manufacturing","volume":"37","author":"Haigney S.","year":"2013","unstructured":"Haigney S. Implementing QbD in sterile manufacturing. Pharm Technol. 2013;37(12):1\u20139. https:\/\/www.pharmtech.com\/view\/implementing-qbd-sterile-manufacturing","journal-title":"Pharm Technol"},{"key":"e_1_3_3_66_1","unstructured":"News CDMO. Recipharm enhances sterile pharmaceutical development with new Bengaluru laboratories; 2025. Available from: https:\/\/pharmasource.global\/content\/news\/cdmo-news\/recipharm-enhances-sterile-pharmaceutical-development-with-new-bengaluru-laboratories\/."},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.07.021"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113758"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.2c03232"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.31083\/FBL28062"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2021v14i6.33733"},{"key":"e_1_3_3_72_1","unstructured":"International Council for Harmonisation. Guideline for elemental impurities Q3D(R1). Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-ich-q3d-elemental-impurities-step-5-revision-1_en.pdf."},{"key":"e_1_3_3_73_1","first-page":"11","article-title":"Guidance for industry: q 8(R2)","author":"U, S. Department of Health and Human Services Food and Drug Administration","year":"2009","unstructured":"U, S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: q 8(R2). Pharm Develop. 2009; Revision 2:11\u201314.","journal-title":"Pharm Develop"},{"key":"e_1_3_3_74_1","unstructured":"Center for Drug Evaluation and Research. Small volume parenteral drug products and pharmacy bulk packages for parenteral nutrition: aluminum content and labeling recommendations. US Food and Drug Administration. Docket Number: FDA-2022-D-2301; 2022. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/small-volume-parenteral-drug-products-and-pharmacy-bulk-packages-parenteral-nutrition-aluminum"},{"key":"e_1_3_3_75_1","unstructured":"US FDA. FY2015 Regulatory science research report: pharmacokinetic\/pharmacodynamic models and pharmacometrics; 2017. Available from: https:\/\/www.fda.gov\/industry\/generic-drug-user-fee-amendments\/fy2015-regulatory-science-research-report-pharmacokineticpharmacodynamic-models-and-pharmacometrics."},{"key":"e_1_3_3_76_1","unstructured":"US FDA. Lifecycle management of drug products. Available from: https:\/\/www.fda.gov\/media\/94067\/download."},{"key":"e_1_3_3_77_1","unstructured":"US FDA. The effective management of change across the ICH Q10 lifecycle. Available from: https:\/\/www.fda.gov\/media\/85273\/download."},{"key":"e_1_3_3_78_1","unstructured":"US FDA. Q8(R2) pharmaceutical development. Available from: https:\/\/www.fda.gov\/media\/71535\/download."},{"key":"e_1_3_3_79_1","unstructured":"US FDA. HACCP principles & application guidelines; 1997. Available from: https:\/\/www.fda.gov\/food\/hazard-analysis-critical-control-point-haccp\/haccp-principles-application-guidelines#guidelines."},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.25004\/ijpsdr.2024.160219"},{"key":"e_1_3_3_81_1","unstructured":"Human Medicines Development and Evaluation. EMA-FDA pilot program for parallel assessment of quality by design applications: lessons learnt and Q&A resulting from the first parallel assessment. European Medicines Agency and U.S. Food and Drug Administration; 2013. EMA\/430501\/2013."}],"container-title":["Drug Development and Industrial Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03639045.2026.2628937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:54:33Z","timestamp":1774871673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03639045.2026.2628937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/03639045.2026.2628937"],"URL":"https:\/\/doi.org\/10.1080\/03639045.2026.2628937","relation":{},"ISSN":["0363-9045","1520-5762"],"issn-type":[{"value":"0363-9045","type":"print"},{"value":"1520-5762","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}